Auranofin and Baicalin Inhibit Clostridioides difficile Growth and Sporulation: An In vitro Study
Clostridioides difficile is a principal cause of hospital-acquired gastrointestinal infections, with sporulation and toxin production being key determinants in the disease pathogenesis. Although infections have been escalating and the complications can be life-threatening, the narrow pipeline of app...
Main Author: | Lamiaa A. Madkour |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Pure and Applied Microbiology
2022-09-01
|
Series: | Journal of Pure and Applied Microbiology |
Subjects: | |
Online Access: | https://microbiologyjournal.org/auranofin-and-baicalin-inhibit-clostridioides-difficile-growth-and-sporulation-an-in-vitro-study/ |
Similar Items
-
Clostridioides difficile Infection: Updates on Epidemiologic Patterns, Diagnostic Tools, and Treatment Modalities
by: Lamiaa Abd El-Fattah MADKOUR
Published: (2023-07-01) -
Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?
by: Chun-Wei Chiu, et al.
Published: (2021-12-01) -
c-di-GMP Inhibits Early Sporulation in Clostridioides difficile
by: Adrianne N. Edwards, et al.
Published: (2021-12-01) -
Protective Effect of Baicalin against <i>Clostridioides difficile</i> Infection in Mice
by: Abraham Joseph Pellissery, et al.
Published: (2021-07-01) -
Outbreak of Clostridioides difficile infection in Silesian district hospital
by: Klaudia T. Szarek, et al.
Published: (2023-06-01)